Adjuvant and neoadjuvant approaches in pancreatic cancer
Current Opinion in Oncology（2023）
Abstract
Adjuvant chemotherapy with mFOLFIRINOX remains the standard of care in fit patients with resected pancreatic cancer, and limited high-level evidence support the use of neoadjuvant therapy in upfront resectable pancreatic cancer.
MoreTranslated text
Key words
pancreatic cancer,neoadjuvant approaches
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined